uMotif and Xperiome Rare Disease Recruitment Collaboration
uMotif has announced its collaboration with Xperiome to bring value to both life science companies conducting clinical trials and the patients participating in them, offering an approach to patient recruitment through a community of patients and an engagement platform to drive retention.
Specifically, the partnership will leverage Xperiome’s knowledge of rare disease to build an understanding of hard-to-reach populations. Xperiome combines these insights with a specialized matching engine, to connect research-ready members to clinical and real-world study opportunities. Then, once enrolled, uMotif’s patient-engagement app will capture large volumes of ePRO, eDiary and symptom data in real-time throughout the duration of a clinical study. The uMotif app empowers patients to manage and collect their own data.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
